Co-Authors
This is a "connection" page, showing publications co-authored by Stefano Barco and Tim Sebastian.
Connection Strength
0.502
-
Enoxaparin for primary thromboprophylaxis in ambulatory patients with coronavirus disease-2019 (the OVID study): a structured summary of a study protocol for a randomized controlled trial. Trials. 2020 Sep 09; 21(1):770.
Score: 0.225
-
Reperfusion treatment for high-risk pulmonary embolism associated with COVID-19. Vasa. 2020 06; 49(4):257-258.
Score: 0.221
-
Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy. Thromb Res. 2020 07; 191:9-14.
Score: 0.055